IBS

New Interactive Tools From ACG Aim to Bring Hope to Millions of IBS Patients Searching for Relief

IBS Signs and Symptoms Tracker Sheds Light on IBS Warning Signs; IBS Treatment Matrix Helps Patients Find Relief BETHESDA, Md., May 29 /PRNewswire-USNewswire/ -- To mark World Digestive Health Day, the American College of Gastroenterology (ACG), in conjunction with global observances of this ...

Review of Probiotic Trial Research Finds Only Bifantis(R) Able to Claim Efficacy for IBS Symptoms

Study Adds to Growing Evidence of B. Infantis 35624 Efficacy in IBS Population CINCINNATI, March 23 /PRNewswire-FirstCall/ -- A review by researchers at Northwestern University (Chicago, IL) and University of Michigan (Ann Arbor , MI) of the utility of probiotics in the treatment of Irri...

Novel IBS treatment developed at UB garners $8.5 million for seven-year clinical trial

BUFFALO, N.Y. -- Irritable bowel syndrome is a chronic, debilitating disorder affecting 25 million people in the U.S -- 14-24 percent of women and 5-19 percent of men. No reliable and satisfactory medical treatment exists for the full range of IBS symptoms, which can cause severe physical and p...

Drug brings relief for many IBS patients who experience constipation

SAN DIEGO, Calif. Many patients may soon find relief from the bloating, cramping, abdominal pain and constipation associated with irritable bowel syndrome, or IBS. Lubiprostone, known by the brand name AMITIZA, was just approved by the U.S. Food and Drug Administration for use in women with IB...

Women With IBS Unable to Switch Off Pain Response

Finding could improve understanding of irritable bowel syndrome and lead to new treatments WEDNESDAY, Jan. 9 (HealthDay News) -- Women with irritable bowel syndrome anticipate and react to pain differently than women without IBS, a new study suggests. The University of California,...

Review of probiotic research finds only Bifantis can claim efficacy vs. placebo for IBS symptoms

PHILADELPHIA October 15, 2007 A new analysis of randomized controlled trials evaluating probiotics in the treatment of irritable bowel syndrome (IBS) has found that Bifantis, Bifidobacterium infantis 35624, the sole ingredient in Align (manufactured by Procter & Gamble), is the only probiotic cu...

New Guidelines Issued for Management of IBS

Group reviews conventional and alternative therapies to treat irritable bowel symptoms THURSDAY, Dec. 18 (HealthDay News) -- A leading organization of gastroenterologists has released new guidelines on the management of irritable bowel syndrome (IBS). The guidelines, issued by the ...

Breath test can discriminate between a bacterial overgrowth and IBS

The gastrointestinal (GI) tract is colonized by bacteria immediately after birth; Escherichia coli, Streptococci and Clostridi are the first bacteria harboured by the colon, followed by anaerobic Enterococci, Lattobacilli and Bacteroidi. These commensal bacteria inhabiting the human intestine (i.e...

The Production and Marketing of IBS Drug Halted by the Chinese Government

The Chinese Food and Drug administration has put a halt to the production and marketing of Novratis AGs Zelnorm Drug, for irritable bowel syndrome, as the risk associated with it outweighs the benefits. The patients are asked to stop taking the medication. The Chinese Drug watchdog posted ...

Gender and Family Size Influences IBS Symptoms in Children

Research presented at the 71st Annual Scientific Meeting of the American College of Gastroenterology suggests that illness behavior, specifically complaints of recurrent// abdominal pain, in girls with mothers who have Irritable Bowel Syndrome (IBS) may be intensified in smaller families, where chi...

More>>

IBS in Medical Technology

Prometheus Presents Findings From Development of PROMETHEUS(R) IBS Diagnostic, First Blood Test for IBS, at ACG Annual Scientific Meeting

SAN DIEGO, Oct. 7 /PRNewswire/ -- Prometheus Laboratories Inc., a specialty pharmaceutical company, today announced findings from its development of PROMETHEUS(R) IBS Diagnostic, the first and only blood test for irritable bowel syndrome (IBS). The findings suggest measurable differences in th...

Oxygen Relieves IBS and Constipation Symptoms in New Clinical Studies

HOUSTON, Feb. 19 /PRNewswire/ -- A natural health company located in Houston, Global Healing Center, Inc., announces the startling results of recent clinical studies indicating their oxygen colon cleanser is extremely successful at relieving symptoms of constipation and Irritable Bowel Syndrom...

Review of Probiotic Trial Research Finds Only Bifantis(R) Able to Claim Efficacy versus Placebo for IBS Symptoms

Of 13 studies analyzed, only Bifantis used appropriate study design to demonstrate efficacy compared with placebo PHILADELPHIA, Oct. 15 /PRNewswire/ -- A new analysis of randomized controlled trials evaluating probiotics in the treatment of irritable bowel syndrome (IBS) has fou...

Ironwood and Forest Present Additional Positive Phase 2b Study Results for Linaclotide in Patients With Irritable Bowel Syndrome With Constipation

...ting treatment." The additional linaclotide presentations being made this week at DDW will be: Abstract 236: Global Endpoints in ibs Clinical Trials: Results from a Phase 2b Study of Linaclotide , an oral presentation by Jeffrey Johnston, M.D., F.A.C.P., F.A.C.G. on Sunday, May 31 a...

New Study Shows Probiotic Strain Effective in Boosting Immune Response to Flu Virus

...body's digestive system and have best been known for their ability to help reduce symptoms of digestive disorders such as irritable bowel syndrome ( ibs ), diarrhea, gas, and bloating . Researchers have long postulated the role probiotics play in boosting immune function through promoting a healthy b...

Pharmos Issues Business Update on Dextofisopam Trial and Financing

...isopam Phase 2b trial for Irritable Bowel Syndrome ibs D+A to a minimum 300 patient trial. The trial is n...t, dextofisopam, is undergoing Phase 2b testing in ibs patients. Dextofisopam has completed a Phase 2a ibs study in which it demonstrated a statistically sig...

New Study Shows Probiotic Strain Effective in Improving Irritable Bowel Syndrome Symptoms

...ting in subjects with irritable bowel syndrome ( ibs ). As many as 25 percent of the U.S. population s...f evidence that certain probiotics can help with ibs and provides hope for ibs sufferers of a new option. (Photo: http://ww...

Pharmos Announces Clinical Results from Phase 2a Trial of Topical Diclofenac NanoEmulsion Cream

...ead product in development, dextofisopam, is undergoing Phase 2b testing in ibs patients. Dextofisopam has completed a Phase 2a ibs study in which it demonstrated a statistically significant effect compared ...

Ironwood and Forest Present Positive Phase 2b Study Results for Linaclotide in Patients With Irritable Bowel Syndrome With Constipation

...stency, straining, abdominal discomfort, bloating, ibs symptom severity, and global assessments were stat...troenterologists. Healthcare costs associated with ibs exceed $25 billion annually. ibs patients fall largely into three subgroups-constip...

Ironwood and Collaborators Present Preclinical Data Demonstrating That Cyclic GMP Alleviates Intestinal Pain

...disorder diagnosed by gastroenterologists. Healthcare costs associated with ibs exceed $25 billion annually. ibs patients fall largely into three subgroups -- constipation-predominant (IBS...

IBS in Medical Products

IBS® Allograft Lumbar

Description:...he affected vertebrae, to restore disc space height and sagittal alignment, and to provide an enviroment for bone fusion between vertebral bodies. The ibs Allograft is designed to promote these goals as well as surgeon skills and training....
Company:Ortho Development Corporation

SmartPill GI Monitoring System

Features:... Track GI pressure, pH, and transit time for the diagnosis of Gastroparesis, Dyspepsia, ibs and other GI motility disorders Track real-time movement of a solid through the GI tract Map the entire GI tract Perform fluid sampling for anti...
Company:SmartPill Corporation

IBS Interbody Spacer

Features:...ates lordosis restoration. Five spacer heights to accurately maintain disc space height. Implant insertion instrument provides positive control of the ibs implant and trial. Cantilever action holds bone graft in compression....
Company:Ortho Development Corporation

IBS in Medical Definition

Pathology

...hipple's ) - Lymphoma Colon Diarrhea - Appendicitis - Diverticulitis - Diverticulosis - IBD ( Crohn's , Ulcerative colitis ) - ibs - Constipation - Colorectal cancer - Hirschsprung's - Pseudomembranous colitis Hernia Inguinal - Femoral - Umbilical - Incis...

IBS in Medical Dictionary

IBS

Irritable bowel syndrome ( IBS ) is a blanket term for a variety of diseases causing discomfort in the gastro-intestinal tract. It is also called spastic colon, is a functional bowel disorder characterized by chronic abdominal... From symptoms to treatment options, find information to...

Exacerbate

...ipps ... On this page: What is Irritable Bowel Syndrome(IBS)? What causes IBS? ... periods, suggesting that reproductive hormones can exacerbate ibs problems. ... As leaders of the former Khmer Rouge regime testify in a human rights tribunal, in harrowing detail, for the killing of more than a ...

Bowel

...able Bowel Syndrome Information plus the Latest News on Irritable Bowel Syndrome ... Can Medicines Relieve Irritable Bowel Syndrome Symptoms? Is ibs ... Introduction Small bowel obstruction (SBO) is a common abdominal pathology. ... A small bowel diameter on plain film greater than 30mm is ...

Aggravated by

...l Dictionary - by Free online English dictionary and encyclopedia. What is ... types of aggravated assaults are those ... This article describes ibs through the syndrome of Liver/Spleen ... aggravated by stress. with severe cramping pain. worse when bending or laying down ... aggravated ...

IBS in Biological News

Review of probiotic trial research finds only Bifantis able to claim efficacy for IBS symptoms

CINCINNATI March 23, 2009 A review by researchers at Northwestern University (Chicago, IL.) and University of Michigan (Ann Arbor, MI) of the utility of probiotics in the treatment of Irritable Bowel Syndrome (IBS) found that Bifidobacterium infantis 35624 was the only probiotic strain out of ...

Research uncovers promising target to treat chronic abdominal pain

...ping, abdominal pain, bloating, constipation and diarrhea. Experts estimate ibs affects between 10 percent and 20 percent of the U.S. population. Viscer...c ceftriaxone used in the study to increase EAAT2 levels may not be optimal ibs therapy because chronic antibiotic use could lead to bacterial resistance a...

World's rarest big cat gets a check-up

...that ongoing analysis of biomedical information will confirm that this individual is in good health," said Alexey Kostyria, Ph.D., senior scientist at ibs and manager for the WCS-IBS project. "This research is critical for conservation of the Far Eastern leopard, as it will help us to determine the risks...

Is yakult helpful in the treatment of irritable bowel syndrome?

... SIBO is a common feature in ibs and in fact may be directly related to the genesis of ibs symptoms. An ERBHAL on a lactulose breath test may...(Yakult(R)) on intestinal fermentation patterns of ibs patients. After 6 week of treatment with 1 x 65 mL...

A first glimpse of the influenza replication machine

...rotein, but it provides interesting insights into how the protein works and how mutations may affect host range." Together with scientists at the ibs they visualized the atomic structure of the protein and discovered a previously overlooked signal that labels it for transport to the human nucleus wh...

IBS in Biological Technology

Prometheus Receives New York State Approval for PROMETHEUS(R) IBS Diagnostic, First Blood Test for Irritable Bowel Syndrome

SAN DIEGO, March 16 /PRNewswire/ -- Prometheus Laboratories Inc., a specialty pharmaceutical and diagnostic company, announced today that it has received New York State approval for PROMETHEUS(R) IBS Diagnostic, the first and only blood test for irritable bowel syndrome (IBS). This novel test inc...

Neurocrine Biosciences Reports First Quarter 2009 Results

...r hormone-dependent diseases in men's and women's health. Corticotropin Releasing Factor (CRF1) Receptor Antagonists for Anxiety/Depression and ibs The CRF collaboration between Neurocrine and GSK has identified multiple unique high affinity and selective antagonists for the CRF1 receptor t...

Pharmos Corporation Reports 2008 Fourth Quarter Results

...rial of its lead compound, dextofisopam, in female ibs patients. Costs of $1,443,000 were incurred during...t, dextofisopam, is undergoing Phase 2b testing in ibs patients. Dextofisopam has completed a Phase 2a ibs study in which it demonstrated a statistically sig...

Pharmos Announces Agreement to Sell Certain CB2 Selective Agonists

...ead product in development, dextofisopam, is undergoing Phase 2b testing in ibs patients. Dextofisopam has completed a Phase 2a ibs study in which it demonstrated a statistically significant effect compared ...

Pharmos Corporation Announces That it Will Cease Operations in Israel

...ead product in development, dextofisopam, is undergoing Phase 2b testing in ibs patients. Dextofisopam has completed a Phase 2a ibs study in which it demonstrated a statistically significant effect compared ...

Pharmos Corporation Reports 2008 Second Quarter Results

...rial of its lead compound, dextofisopam, in female ibs patients. The Phase IIb trial is expected to enrol...t, dextofisopam, is undergoing Phase 2b testing in ibs patients. Dextofisopam has completed a Phase 2a ibs study in which it demonstrated a statistically sig...

AMITIZA(R) (lubiprostone) 8 mcg Now Available to Treat Irritable Bowel Syndrome with Constipation in Adult Women

...ritable Bowel Syndrome with Constipation (IBS-C) ibs is a disorder characterized by symptoms including ...nd/or diarrhea. There are three main types of IBS: ibs with constipation (IBS-C), ibs with diarrhea (IBS-D) and...

Pharmos Corporation to Present at the Rodman & Renshaw 5th Annual Global Healthcare Conference

...s. The Company's lead product, dextofisopam, is being studied in a Phase 2b clinical trial in patients with IBS. Dextofisopam has completed a Phase 2a ibs study in which it demonstrated a statistically significant effect compared to placebo on the primary efficacy endpoint of adequate relief (n=141, p=0....

Pharmos Corporation Reports 2008 First Quarter Results

...ny advanced a Phase IIb trial of its lead compound, dextofisopam, in female ibs patients, which is expected to enroll approximately 480 patients in about 7... clinical trial in patients with IBS. Dextofisopam has completed a Phase 2a ibs study in which it demonstrated a statistically significant effect compared ...

Pharmos Corporation Announces President & COO Alan L. Rubino to Leave Company

...ing the Vela acquisition, Mr. Rubino has been focused on key business development priorities and the Company's Phase 2b clinical trial for its leading ibs drug candidate, dextofisopam. Over recent months, Pharmos has announced a series of restructurings of its operations in Israel in order to manage an...